Memorial Sisli Hospital
El costo de la terapia con células madre de cordón umbilical en Turquía suele oscilar de $5,000 a $9,200. Los precios varían según la clínica, la experiencia del médico y el protocolo de tratamiento (número de infusiones de células madre, atención ambulatoria u hospitalaria). En Estados Unidos, el costo promedio es de $15,000 (según ISCT). Esto significa que la terapia con células madre de cordón umbilical en Turquía puede costar aproximadamente un 53% menos que en EE. UU.
En Turquía, el precio generalmente incluye la consulta inicial, el procesamiento en laboratorio de la sangre o tejido del cordón umbilical, el aislamiento de las células madre, el procedimiento de infusión y las visitas básicas de seguimiento. En EE. UU., los costos de la terapia con células madre a menudo solo incluyen el tratamiento en sí, con cargos separados por las tarifas de laboratorio, consultas y atención de seguimiento. Siempre confirmar qué servicios están incluidos en el paquete de cada clínica.
¿Por qué elegir Turquía para la terapia con células madre del cordón umbilical?
Accede a soluciones avanzadas de terapia con células madre del cordón umbilical en clínicas de confianza .
| España | Turquía | México | |
| Tratamiento de sangre de cordón umbilical | de $7,500 | de $5,000 | de $4,500 |
Bookimed no añade cargos adicionales a los precios de Tratamiento de sangre de cordón umbilical. Las tarifas proceden de las listas de precios oficiales de las clínicas. Pagará directamente en la clínica por su Tratamiento de sangre de cordón umbilical a su llegada al país.
Bookimed está comprometido con su seguridad. Solo trabajamos con las clínicas que mantienen altos estándares internacionales en Tratamiento de sangre de cordón umbilical y tienen las licencias necesarias para atender a pacientes internacionales en todo el mundo.
Bookimed ofrece asistencia experta gratuita. Un coordinador médico personal le apoya antes, durante y después del tratamiento, resolviendo cualquier problema. Nunca estará solo en su viaje médico de Tratamiento de sangre de cordón umbilical.
Día 1
Dia 2
Día 3
Día 4
Dia 5
Semana 1
Semana 2
Semana 3
Tenga en cuenta que el caso de cada paciente es individual y puede variar. Consulte siempre con su especialista para obtener información precisa.
Con más de 20 años en la investigación de células madre, el Dr. Karaöz fue pionero en el primer centro institucional de I+D de células madre de Turquía en la Universidad de Kocaeli. Su trabajo ha avanzado los tratamientos para afecciones como la parálisis cerebral y la esclerosis múltiple.
Profesor Asociado de Enfermedades Infecciosas con investigación en la Facultad de Medicina de Yale – se especializa en tratamientos avanzados en el Hospital de Distrito Medipol Acibadem.
El Prof. Asociado Nail Paksoy se especializa en oncología médica en el Hospital Medipol Bahçelievler, con una extensa investigación en tratamientos avanzados contra el cáncer.
El Prof. Dr. Ali Inal cuenta con más de 25 años de especialización en inmunología y terapia con células madre, y actualmente dirige la investigación en el Hospital Universitario Başkent de Estambul.
Umbilical cord stem cell therapy in Turkey is generally safe at JCI-accredited clinics using Good Manufacturing Practice (GMP) laboratories. Common side effects include temporary fever, injection site redness, or fatigue. While rare, serious risks include blood clots, infection from contaminated cultures, or immune reactions to cell media.
Bookimed Expert Insight: High-quality Turkish centres use closed-system cell processing rather than manual handling. Prof. Erdal Karaöz at Liv Hospital managed ministry-approved clinical trials using these strict protocols. Patients should prioritise clinics with on-site GMP laboratories. This significantly reduces the risk of cell contamination during transport or cryobanking.
Patient Consensus: Patients in Turkey often report short-term anxiety or irritability similar to high-dose steroids. Most emphasise that verifying laboratory sterility and GMP compliance is vital. These factors are more important than hotel-style amenities or package inclusions.
Verifying clinic quality for stem cell therapy in Turkey involves confirming Joint Commission International (JCI) accreditation. You should also check for Good Manufacturing Practice (GMP) laboratory standards. Reliable centres like Liv Hospital Ulus and Memorial Şişli Hospital use closed-system processing. They also use Ministry-approved clinical trial protocols for cell viability and patient safety.
Bookimed Expert Insight: Data shows Turkey’s leading stem cell centres maintain internal GMP labs (LivMedCell). Choosing a clinic with on-site production ensures higher cell freshness and stricter sterility. Istanbul centres now serve patients from over 167 countries.
Patient Consensus: Patients in Turkey recommend requesting written cell dose and processing data. They suggest prioritising doctor-led clinics over marketing-focused centres. Success often depends on clear follow-up plans. Patients should also verify the exact cell source, like umbilical cord matrix, before arrival.
Turkish specialists use umbilical cord mesenchymal stem cells to treat chronic neurological, autoimmune, and musculoskeletal conditions. Common applications include cerebral palsy, multiple sclerosis, spinal cord injuries, and osteoarthritis. Accredited facilities like Liv Hospital Ulus use GMP-standard labs for precise cell isolation and sterile processing.
Bookimed Expert Insight: Success in Turkey often links to what happens after the injection. Specialists like Dr. Asena Paran or Dr. Erdal Karaöz emphasise neuroplasticity-focused rehabilitation after therapy. This structured post-treatment support helps patients translate biological cellular changes into functional improvements. These include better walking or reduced spasticity.
Patient Consensus: Patients in Turkey typically focus on symptom relief for multiple sclerosis. They also seek help for spinal cord injuries and chronic nerve pain. Most report incremental gains in bladder control and sensation rather than total cures.
Turkey is a leading centre for umbilical cord stem cell therapy. It has strong Good Manufacturing Practice (GMP) laboratories and JCI-accredited hospitals. Specialists use allogeneic mesenchymal stem cells from umbilical cord matrix. These treat complex neurological, orthopaedic, and autoimmune conditions.
Bookimed Expert Insight: Bookimed data shows Turkey provides fast access to regenerative medicine compared to Australia. While Australian patients often face long waits for trials, Turkish centres have virtually no waiting lists. Medipol Mega University Hospital serves 1,000,000+ patients annually. This high-volume environment allows clinicians to refine protocols across thousands of cases.
Patient Consensus: Patients value the combination of cost-effective care and professional medical-tourism support in Turkey. Many describe a friendly atmosphere. They find that integrated travel and interpretation services make navigating complex treatments much easier.
Umbilical cord stem cells in Turkey are collected from donors after healthy deliveries using sterile, non-invasive methods. Processing occurs in specialised Good Manufacturing Practice (GMP) laboratories. Technicians isolate and expand mesenchymal stem cells (MSCs) from the cord matrix before cryopreservation or clinical use.
Bookimed Expert Insight: Turkish facilities like Liv Hospital Ulus often have internal GMP-standard production centres on-site. This allows professors like Dr Erdal Karaöz to oversee the entire chain from isolation to infusion. These integrated hospital labs provide higher cell viability than clinics that outsource their manufacturing.
Patient Consensus: Patients value transparency regarding donor screening and laboratory standards in Turkey. Many recommend asking for written proof of cell viability and passage numbers. This confirms the treatment is fresh and potent.
An umbilical cord stem cell treatment trip to Turkey typically lasts 5 to 10 days. Simple cases may require only 3 nights. Complex neurological or orthopaedic conditions often involve a 14-day stay. This extended window allows for rehabilitation and physical therapy alongside the cell administration.
Bookimed Expert Insight: Turkish specialists often differentiate between the travel window and the therapeutic window. While the procedure finishes in days, clinics like Rumi Pulse focus on the 3 to 6 month window for results. Choosing a centre with established Good Manufacturing Practice labs helps ensure cells are processed locally. This often reduces the wait time for administration.
Patient Consensus: The trip is usually a short medical visit focused on the procedure with brief in-country monitoring. People suggest planning for gradual improvements over 12 months rather than expecting immediate results during the stay in Turkey.